Context: A new and highly sensitive method for the determination of gabapentin (GBP), this method is of high importance in the assessment of GBP and other pharmaceutical preparations. GBP is a widely used antibiotic. There is a big challenge of analysis of anti-epilepsy drugs due to their instability and sensitivity to various conditions. The simple, sensitive, precise, and kinetic spectroscopy method was used to measure GBP in some pharmaceuticals developed and validated. Objective: The objective of the study was to develop a simple, sensitive, accurate, and kinetic spectroscopy method for the measurement of GBP in a pharmaceutical product. Materials and Methods: The current method was based on the spectral kinetic examination of epileptics (GBP) with potassium permanganate in alkaline medium at room temperature. Absorption of the stained manganese ions of the product was absorbed at 605 nm. Results: The concentration of GBP was calculated using the calibration equation for the time method and the initial rate method. The above method is used to determine GBP from 2.0 to 20 μg/mL. The BER Act was applied to roads within the range of concentrations used for analysis. The limit of quantification and limit of detection, equal to 0.640 and 1.940, were calculated, respectively. The relative standard deviation values was found to be 0.345% and Recovery values were 99.38 and 0.50%, respectively. Conclusion: The proposed and developed method is sensitive, accurate, and tolerable and can be used for the routine analysis of GBP in various pharmaceuticals. The proposed method was successfully applied to the determination of the drug jabapentin in the pharmaceuticals and the validation of the statistical data. The results were compared to the reference method showed good compatibility.
INTRODUCTION
T he drug gabapentin (GBP) has a chemical formula of C 9 H 17 NO 2 . The molecular mass of 171.237 g/mol is known chemically as aminomethyl cyclohexane acetic acid; the trade names are Garrex, Neuroplex, Neurontin, Neurona, captain, and Conventin. [1] GBP as an anticonvulsant, it can be used to treat seizures and strokes. It can be used as a barrier to blood in the brain. This can be used to treat seizures and strokes. [2] [3] [4] GBP is a complementary tool for other anti-epileptic drugs in adult patients who do not have sufficient control over the effects of narcotic drugs in cases of molecular seizures and stroke. [5] The treatment helps to prevent seizures or seizures in the brain and helps control them, so it is used (as a single treatment or with other treatments) to control certain types of seizures or epileptic seizures. It also regulates the work of a number of neurotransmitters responsible for the delivery of pain, leading to its use in the treatment of some types of neuropathic pain. Treatment does not cure epilepsy but helps control seizures in terms of reducing recurrence, so it is not allowed to discontinue treatment without consulting the doctor once the patient has improved. The seizures may recur after discontinuation of treatment. [6] GBP has a structural analogy of the amino acid (Butyric) and the inhibitory DNA (gammaaminobutyric acid 1). Spectrophotometric measurements, high-performance liquid chromatography, serial injection measurements, and automated spectrum measurements were performed to determine the drug's GBP. [7] The interaction of potassium permanganate (KMnO 4 ) as a potent oxidative
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agent with alginate in the alkaline medium was performed. The spectral method was used at the maximum absorption spectra of 605 nm. The GBP was shown with the oxidative factor of green color in the visible and ultraviolet region of the spectrum. [8] The Objective of the Study
The objective of the study was to study the development of a new spectral method of high and simple selectivity for the determination of GBP in pharmaceutical drugs.
EXPERIMENTAL
All spectral absorption values were performed using a German-made high-sensitivity spectrometer operating in the two visible areas of the spectrum and ultraviolet (A Jena Model 1100).
MATERIALS AND METHODS

Materials
• GBP pharmaceutical grade 99.5% from Sun Pharmaceuticals, Mumbai, India.
• 100 mg Gaba Plus capsules purchased from Platinum Pharma (Pvt.) Ltd.
• Karachi, (Pakistan) and Gabapin-300 (300 mg GBP per capsule) from Intas Pharmaceuticals, Dehradun, India.
• Neurontin capsules (Labeled to found 300 mg GBP)
were product from Godecke AG/Germany. • Potassium permanganate (KMnO 4 ) (Merck, Germany).
• Sodium hydroxide (NaOH) from (Merck, Germany).
• Hydrochloric acid (HCl) from (Merck, Germany).
Molecular Formula of GBP
Methods
Preparation of reagent and standard solutions
All the solvents and reagents used for the experiment were 99.9% pure. Deionized water was also used with a high purity of 0.055 µs/cm. [9] A standard solution of 100 ml of 250 mg/L of standard pharmaceuticals was prepared in distilled water. A concentration of 0.158 KMnO 4 was prepared in 100 ml of distilled water. 0.5 m of sodium hydroxide was prepared by dissolving 2 g of NaOH in 100 ml distilled water and calibrating sodium hydroxide solution with standard hydrochloric acid. [10] Procedure of analysis standard material and pharmaceuticals
The working solution was prepared with a combination of GBP concentrations (2.0-20 mg/L) and the transfer of these concentrations, respectively, to 25 ml of volumetric flasks, plus 2 ml of KMnO 4 solution (0.1 m) and 1.5 ml of sodium hydroxide solution. Then complete the volume with deionized water. After 15 min, absorption was measured at a 605 nm wavelength and compared with a detector set at the same time. The calibration curve of the absorption values was plotted against the final concentration of the mg/L unit . [11, 12] A range of sample concentrations (1-1000) mg/L were prepared by dissolving 27 mg GBP in deionized water and taking 25 ml of each concentration for analysis. From the range of selected concentrations the standard curve was drawn.
RESULTS
The absorption spectrum at the maximum value (λ max ) for GBP was recorded at 200 nm using deionized water as a solvent. GBP was mixed and mixed with potassium permanganate at 25°C, as shown in Figures 1. The absorption spectra of the green mix solution (maximum absorption at 605 nm) were recorded against an blank.
Gapapentin was estimated in two methods. The first was the reaction of GBP with potassium permanganate at the concentration of 0.8 × 10 -2 m. The absorbance of the reaction mixture was measured at a maximum wavelength of 605 nm, and the other comparison method was made using GBP with potassium permanganate at 0.6 × 10 −4 m concentration at the same maximum wavelength. Two types of curves were obtained according to Figure 1a and b, which shows the effect of different concentrations of potassium permanganate as a potent oxidative agent on the kinetics of interaction with GBP. The effectiveness of GBP toward oxidizing agents such as potassium permanganate explains its uses extensively to relieve pain, especially nerve pain, and epilepsy of all kinds.
DISCUSSION
Reliability of Interaction Variables
The effect of different parameters on the development of single-color amygdala solutions was studied separately, and all factors studied and confirmed for subsequent studies were observed. These variables include KMnO 4 concentration effect, sodium hydroxide concentration effect, temperature, and time. GBP was found to interact with KMnO 4 in the center of alkali to produce a green solution with a peak of 605 nm [ Figure 1 ]. The various experimental factors that influence the evolution and stability of the reaction output at this wavelength have been carefully studied, and several studies have been conducted for the purpose of improving them. [12] [13] [14] 
Effect of Potassium Permanganate Concentrations
The KMnO 4 concentration effect was studied on the absorbance in the range (0.2 × 10 ) KMnO4 solution was used to obtain the maximum absorbance value in 15 min. [15] 
Effect of Sodium Hydroxide Concentrations
The effect of sodium hydroxide concentrations was studied by taking a constant concentration of GBP (0.6 × 10 −4 m) plus 2.0 ml of potassium permanganate solution at 0.1 m concentration and different volumes of sodium hydroxide at 0.5 m concentration within a range of volumes (0.5-4.0) ml. As shown in Figure 3 , the highest absorption value was obtained when adding 1.5 ml of 0.5 M (3 × 10 −2 m) sodium hydroxide solution, the increase in the volume of sodium hydroxide added to the low spectral absorption values. [16, 17] 
Effect of Time Required for Reactance
The effect of the time needed for interaction between GBP and KMnO 4 was studied in the basal medium [ Figure 4 ]. The oxidation reaction was performed for periods of 2-35 min.
The oxidation reaction was achieved within 15 min, and the maximum wavelength was obtained at 605 nm. The solutions turned into sour solutions after 50-60 min. Absorption values increase over time. [18] Effect of Temperature Required for Reactance At 25°C, GBP reaction with potassium permanganate was observed. The reaction rate was significantly increased with the increase in the color of the mixture, but avoiding work at high temperatures caused the release of MnO 2 from the oxidation reaction. [19] 
Study of Kinetics of Materials Reactant
Rate=K[Drug]n[KMnO 4 ]m
The gradual changes in color intensity over time were due to differences in energy kinetics of the reaction of GBP with potassium permanganate in the basal medium as shown in Figure 5 . Where the concentrations of potassium permanganate were within the linear range of the reaction (0.8 × 10 −2 m), the equation of kinetics of reaction can be written as follows: K` is the constant of the ratio of the reaction order and n represents the order of the interaction. The above equation can be considered the logarithmic form of the reaction as follows:
Log rate=log K`+n log [Drug]
At a range of GBP concentrations, initial reaction rates at 605 nm were determined by measuring the value of the initial contact tangent of the time curves during the first 35 min of the reaction as shown in Figure 5 . With correlation coefficient equal to R 2 = 0.9049. The value of n in the former equation shows that the reaction is first order.
The Credibility of the Kinetic Method
To determine the ranges of GBP concentrations, several experimental tests were performed using the relationship between fixed absorption values and time values.
1/t = 0.027 [Drug] + 3 × 10
-5 with correlation coefficient equal to R2 = 0.989
Absorbance Method
GBP reaction rate data were recorded within the range (2.0-20.0 mg/L). The selective absorption period was determined as shown in Table 1 and time was measured in seconds. [20] The standard calibration equation was also obtained by the time-frame (1/t) versus the initial concentration of the GBP drug [ Table 2 ].
When the calibration graphs were plot at 15 min, the most acceptable linearity was obtained as shown in Table 3 
Verification of the Credibility of the Analytical Method
The analytical method was validated by linear values, accuracy, sensitivity, precision, and recovery. [22] The Linearity and Sensitivity [23] The relationship between absorption values and GBP concentration values was determined within the range 2.0-20.0 mg/L at 605 nm at optimal conditions. It was observed that the relationship was linear for all values of GBP concentrations, as shown in Figure 6 .
The calibration graph can be described by the following equation: y = 0.067 x + 0.021 (R² = 0.9990, n = 6) where Y is represented the absorption, and X equal to the concentration of GBP in concentration with mg/L.
The analytical parameters such as correlation coefficient, molar absorptivity, Sandellʼs sensitivity, limit of detection (LOD), and limit of quantification (LOQ) are calculated and listed in Table 3 . The correlation coefficient, intercept and slope for the calibration data are summarized in Table 3 .
The below formula was used to calculate (LOD) and (LOQ): LOQ=10s/b
LOD=3:3s/b
Whereas is equal to the standard deviation of the intercept, and b represented the slope of the calibration curve. [24] The Precision and Accuracy [25] The precision and accuracy of the spectral study showed four levels of GBP concentration using five concentrations per sample. Table 4 ].
The Applications of Method
The current method of analysis has been used successfully in the estimation of GBP in pharmaceutical preparations. The results of the method used indicate the precision and accuracy of the good evaluation of the drug GBP. Table 5 shows the results of application of the current method where the recovery values ranged from 103.020 to 97.470%. The current method is also free of interferences.
CONCLUSION
The results obtained from the measurement of the GBP interaction variables indicate that the proposed method is simple, fast, and high-sensitivity and can be easily applied to determine GBP in its pure form as standard and pharmaceutical preparations at a maximum absorption of 605 nm. A range of temperatures can be controlled during the interaction of GBP with potassium permanganate. The current spectral measurement method can be used in quality control laboratories for GBP in pharmaceuticals and biological samples.
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